Table 1. Frequency of mucositis/stomatitis, xerostomia and dysgeusia after cancer treatment with certain molecularly targeted drugs.
†multiple tyrosine kinase inhibitor, ‡in combination with radiotherapy, §in combination with 5-FU and leucovorin, ¶in patients with previous bevacizumab treatmentSIDS: Frequent oral side-effects of targeted cancer therapy